Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 102M 90.94M 83.9M 76.23M 143M 9.65B 145M 1.01B 398M 5.06B 382M 374M 16.02B | P/E 2026 * |
-4.47x | P/E 2027 * | -70.6x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 90.94M 83.9M 76.23M 143M 9.65B 145M 1.01B 398M 5.06B 382M 374M 16.02B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 0.24x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 102M | ||
| -4.10% | -8.54% | +40.05% | +66.99% | 63.29B | ||
| -0.54% | +7.15% | +10.64% | +72.90% | 54.89B | ||
| -0.29% | +3.71% | +9.13% | +91.21% | 53.28B | ||
| +0.61% | +2.69% | +27.75% | +50.97% | 45.81B | ||
| -1.08% | +2.19% | +21.92% | +131.38% | 43.46B | ||
| -3.39% | -0.83% | +254.27% | +571.04% | 40.23B | ||
| -1.67% | +6.70% | +14.42% | +56.67% | 33.45B | ||
| +1.19% | -4.98% | +29.01% | -0.76% | 23.7B | ||
| -1.09% | +5.12% | +35.71% | +26.87% | 23.76B | ||
| Average | -1.79% | +0.46% | +49.21% | +118.59% | 42.43B | |
| Weighted average by Cap. | -1.34% | +0.59% | +47.34% | +122.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.4M 53.91M 49.74M 45.19M 84.77M 5.72B 86.08M 599M 236M 3B 227M 222M 9.5B | 431M 385M 355M 323M 605M 40.85B 615M 4.28B 1.69B 21.4B 1.62B 1.58B 67.81B |
| Net income | -41.4M -36.95M -34.09M -30.97M -58.11M -3.92B -59M -411M -162M -2.05B -155M -152M -6.51B | -4.5M -4.02M -3.71M -3.37M -6.32M -426M -6.41M -44.64M -17.59M -223M -16.89M -16.53M -707M |
| Net Debt | - | - |
Employees
-
















